INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
Position in SGMOQ — Sangamo Therapeutics, Inc
CIK 1818604
ORLANDO, FL
Position in SGMOQ
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$7,000
-$4,760 QoQ
Shares Held
28,000
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
9 quarters on record
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC holds $2,775,775 across 54 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,001 | $624,163 | |
| 2 | OMER |
Omeros Corp
|
40,400 | $384,204 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,825 | $241,536 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
6,057 | $236,283 | |
| 5 | ONCY |
Oncolytics Biotech Inc
|
201,260 | $191,197 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
326 | $161,933 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
1,667 | $130,476 | |
| 8 | EDIT |
Editas Medicine, Inc.
|
31,207 | $101,110 |
All Filings in SGMOQ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,000 | 28,000 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $11,760 | 28,000 | Shares | Sole | 2026-02-03 | |
| 2025-06-30 | $18,360 | 34,000 | Shares | Sole | 2025-07-29 | |
| 2024-12-31 | $37,281 | 36,550 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $30,215 | 34,731 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $14,808 | 41,135 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $23,205 | 34,635 | Shares | Sole | 2024-04-11 | |
| 2023-03-31 | $1,936 | 1,100 | Shares | Sole | 2023-04-19 | |
| 2021-03-31 | $9,397 | 750 | Shares | Sole | 2021-04-19 | |
| No filing history on record for this holder in this stock. | ||||||